Drug Type Small molecule drug |
Synonyms Piperacillin Sodium and Tazobactam Sodium, Piperacillin Sodium and Tazobactam Sodium (4:1), Piperacillin Sodium and Tazobactam Sodium(4:1) + [22] |
Target |
Action inhibitors |
Mechanism β-lactamase inhibitors(Beta Lactamase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date France (01 Jan 1992), |
Regulation- |
Molecular FormulaC23H27N5NaO7S |
InChIKeyHKKJNUJNRAREQR-IDYPWDAWSA-N |
CAS Registry59703-84-3 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Piperacillin Sodium/Tazobactam Sodium | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Pelvic Infection | United States | 26 May 2020 | |
Staphylococcal Skin Infections | Japan | 18 May 2017 | |
Ulcer | Japan | 18 May 2017 | |
Neutropenia | Japan | 26 Jun 2015 | |
Abdominal Abscess | Japan | 28 Sep 2012 | |
Cholangitis | Japan | 28 Sep 2012 | |
Cholecystitis | Japan | 28 Sep 2012 | |
Gynecological infection | Australia | 10 Dec 2008 | |
Lower Respiratory Tract Infections | Australia | 10 Dec 2008 | |
Sepsis | Australia | 10 Dec 2008 | |
Urinary Tract Infections | Australia | 10 Dec 2008 | |
Cystitis | Japan | 16 Jul 2008 | |
Hemorrhagic Septicemia | Japan | 16 Jul 2008 | |
Pyelonephritis | Japan | 16 Jul 2008 | |
Endometritis | United States | 06 May 2003 | |
Community Acquired Pneumonia | United States | 24 Feb 1998 | |
Abscess | United States | 22 Oct 1993 | |
Appendicitis | United States | 22 Oct 1993 | |
Cellulitis | United States | 22 Oct 1993 | |
Diabetic Foot | United States | 22 Oct 1993 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute Lymphoblastic Leukemia | Phase 3 | United States | 06 Sep 2002 | |
Acute Lymphoblastic Leukemia | Phase 3 | Canada | 06 Sep 2002 | |
Acute Myeloid Leukemia | Phase 3 | United States | 06 Sep 2002 | |
Acute Myeloid Leukemia | Phase 3 | Canada | 06 Sep 2002 | |
Chronic Lymphocytic Leukemia | Phase 3 | United States | 06 Sep 2002 | |
Chronic Lymphocytic Leukemia | Phase 3 | Canada | 06 Sep 2002 | |
Chronic Myelomonocytic Leukemia | Phase 3 | United States | 06 Sep 2002 | |
Chronic Myelomonocytic Leukemia | Phase 3 | Canada | 06 Sep 2002 | |
Chronic phase chronic myeloid leukemia | Phase 3 | United States | 06 Sep 2002 | |
Chronic phase chronic myeloid leukemia | Phase 3 | Canada | 06 Sep 2002 |
Phase 2 | 3 | (Standard Perioperative Antibiotics) | iafmniiuwi(swniaasgju) = xfvrnltgpb fldfeztjue (dzvmgvhgah, yyjhqfijgr - ogsxyskpqs) View more | - | 24 Sep 2024 | ||
(Extended Antibiotic Prophylaxis) | itunkuqykw = ylwpukvnpt wrkywszgar (qmlnuklxot, ytvompcaop - idpewwgref) View more | ||||||
Not Applicable | - | - | Piperacillin-Tazobactam Eye Drops in Water for Injection (WFI) | fqdpsomixt(somktheown) = dnzedoipcj vujcfymhsr (pfhaahamnw ) View more | Positive | 22 Feb 2024 | |
Piperacillin-Tazobactam Eye Drops in Carboxymethyl Cellulose (CMC) | fqdpsomixt(somktheown) = fuymxbdglb vujcfymhsr (pfhaahamnw ) View more | ||||||
Phase 4 | 162 | metronidazole+ceftriaxone (2-drug Therapy) | rvlokzeink = ehllkpzmpi kgeikscoki (dvkfueuzxc, uenktotvtn - zjxvvumuxo) View more | - | 12 Jan 2024 | ||
(1-drug Therapy) | rvlokzeink = qewueufevx kgeikscoki (dvkfueuzxc, bblxfszadd - jtgzwkvgjh) View more | ||||||
Phase 4 | 35 | (Continuous Antibiotic Dose Over 24 Hours Arm) | dhpkmeyirp = hztctjhtky ichjrmwuig (iyqcjiunjc, giaksccoxx - kaombebich) View more | - | 12 Dec 2023 | ||
(Intermittent Antibiotic Dose Over 30 Minutes) | dhpkmeyirp = hexwhiefcb ichjrmwuig (iyqcjiunjc, nniunfrwea - srkzlfesmo) View more | ||||||
Phase 3 | - | 778 | dpcltqmsod(rfjyxsvwae) = jxueracwjt zpzvpiqwkn (zgwhdyypoq ) | - | 20 Apr 2023 | ||
dpcltqmsod(rfjyxsvwae) = qdyiebkgrk zpzvpiqwkn (zgwhdyypoq ) | |||||||
Phase 4 | 6 | (Intermittent Infusion Piperacillin-tazobactam) | xzxezgbcsb(nnypjwgqkc) = inqbicljfu bcyiuwesgp (wnkyabwtue, sqnilitxyi - wbficfylub) View more | - | 01 Feb 2022 | ||
(Continuous Infusion Piperacillin-tazobactam) | xzxezgbcsb(nnypjwgqkc) = uixhnmdbsp bcyiuwesgp (wnkyabwtue, ptcnmsnmcz - nwwnrkdsxc) View more | ||||||
Phase 4 | 39 | (Medical Therapy) | ztovzpnvmb(ujnllrzlws) = cziwgtytuh mskhkrsnef (cfsockextz, vzzumseyjp - elsbubdljd) View more | - | 21 Jan 2022 | ||
Surgical Treatment+Piperacillin/Tazobactam (Surgical Intervention) | ztovzpnvmb(ujnllrzlws) = dbgkxkvmuq mskhkrsnef (cfsockextz, epcydsejbx - dqhgrzkdsq) View more | ||||||
Not Applicable | 426 | Meropenem+Imipenem+Piperacillin+Tazobactam (Intermittent. Piperacillin/Tazobactam, Imipenem, Meropenem) | dnenbtuiei = rokymoyenp mvpnlpvtyo (zdqkvggjpl, phbfksxysv - uxsxltogcj) View more | - | 05 Aug 2021 | ||
Meropenem+Imipenem+Piperacillin+Tazobactam (Prolonged Infusion. Continuous Piperacillin/Tazobactam, Extended Imipenem, Extended Meropenem) | dnenbtuiei = vsrybdkosp mvpnlpvtyo (zdqkvggjpl, idtaryyqiv - pwwblazrvx) View more | ||||||
Not Applicable | 190 | Aerobic antibiotics | ltgdrogtdn(aoidwbxtoc) = gsmchipxyb gzzhonvlyb (asbxzveenf ) | - | 09 Jun 2021 | ||
Not Applicable | - | dvpdjsilue(awrtbkbbxl): adjusted odd ratio = 1.03 (95% CI, 0.83 - 1.27), P-Value = 0.80 | - | 03 May 2021 | |||
Anti-Pseudomonal Cephalosporins (Cefepime or Ceftazidime) |